|
EP1577816A3
(en)
*
|
1996-09-04 |
2006-08-02 |
Intertrust Technologies Corp. |
Trusted infrastructure support systems, methods and techniques for secure electronic commerce and rights management
|
|
US6184226B1
(en)
*
|
1998-08-28 |
2001-02-06 |
Scios Inc. |
Quinazoline derivatives as inhibitors of P-38 α
|
|
US6982260B1
(en)
|
1999-11-22 |
2006-01-03 |
Warner-Lambert Company |
Quinazolines and their use for inhibiting cyclin-dependent kinase enzymes
|
|
DZ3377A1
(fr)
|
1999-12-24 |
2001-07-05 |
Aventis Pharma Ltd |
Azaindoles
|
|
US7473691B2
(en)
|
2000-09-15 |
2009-01-06 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
|
US6660731B2
(en)
*
|
2000-09-15 |
2003-12-09 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
|
WO2002022604A1
(en)
*
|
2000-09-15 |
2002-03-21 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
|
EP1347972A1
(en)
*
|
2000-12-19 |
2003-10-01 |
Smithkline Beecham Plc |
Pyrazolo 3,4-c]pyridines as gsk-3 inhibitors
|
|
CA2432131C
(en)
*
|
2000-12-21 |
2008-07-08 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
|
MXPA03005696A
(es)
|
2000-12-21 |
2003-10-06 |
Glaxo Group Ltd |
Pirimidinaminas como moduladores de angiogenesis.
|
|
US7276523B2
(en)
|
2001-03-30 |
2007-10-02 |
Smithkline Beecham Corporation |
Aminopyridine derivatives as estrogen receptor modulators
|
|
WO2002092573A2
(en)
*
|
2001-05-16 |
2002-11-21 |
Vertex Pharmaceuticals Incorporated |
Heterocyclic substituted pyrazoles as inhibitors of src and other protein kinases
|
|
GB0115109D0
(en)
|
2001-06-21 |
2001-08-15 |
Aventis Pharma Ltd |
Chemical compounds
|
|
US6939874B2
(en)
|
2001-08-22 |
2005-09-06 |
Amgen Inc. |
Substituted pyrimidinyl derivatives and methods of use
|
|
US7115617B2
(en)
|
2001-08-22 |
2006-10-03 |
Amgen Inc. |
Amino-substituted pyrimidinyl derivatives and methods of use
|
|
US20030176437A1
(en)
|
2001-08-31 |
2003-09-18 |
D.M. Watterson |
Anti-inflammatory and protein kinase inhibitor compositions and related methods for downregulation of detrimental cellular responses and inhibition of cell death
|
|
WO2003030909A1
(en)
*
|
2001-09-25 |
2003-04-17 |
Bayer Pharmaceuticals Corporation |
2- and 4-aminopyrimidines n-substtituded by a bicyclic ring for use as kinase inhibitors in the treatment of cancer
|
|
BR0212841A
(pt)
|
2001-09-26 |
2004-08-03 |
Pharmacia Italia Spa |
Derivado ativo de aminoindazole como inibidores de cinase, processo para sua preparação e composições farmacêuticas que os contém
|
|
TWI330183B
(enExample)
*
|
2001-10-22 |
2010-09-11 |
Eisai R&D Man Co Ltd |
|
|
SE0104140D0
(sv)
|
2001-12-07 |
2001-12-07 |
Astrazeneca Ab |
Novel Compounds
|
|
CA2469316A1
(en)
*
|
2001-12-07 |
2003-06-19 |
Vertex Pharmaceuticals, Inc. |
Pyrimidine-based compounds useful as gsk-3 inhibitors
|
|
US20030187026A1
(en)
|
2001-12-13 |
2003-10-02 |
Qun Li |
Kinase inhibitors
|
|
DE60210819T2
(de)
|
2001-12-17 |
2007-04-19 |
Smithkline Beecham Corp. |
Pyrazolopyridazinderivate
|
|
US20030158195A1
(en)
|
2001-12-21 |
2003-08-21 |
Cywin Charles L. |
1,6 naphthyridines useful as inhibitors of SYK kinase
|
|
AU2002361846A1
(en)
*
|
2001-12-21 |
2003-07-15 |
Bayer Pharmaceuticals Corporation |
Quinazoline and quinoline derivative compounds as inhibitors of prolylpeptidase, inducers of apoptosis and cancer treatment agents
|
|
TW200406390A
(en)
|
2002-01-17 |
2004-05-01 |
Neurogen Corp |
Substituted quinazolin-4-ylamine analogues
|
|
TWI329105B
(en)
|
2002-02-01 |
2010-08-21 |
Rigel Pharmaceuticals Inc |
2,4-pyrimidinediamine compounds and their uses
|
|
JP4656838B2
(ja)
*
|
2002-02-06 |
2011-03-23 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
Ｇｓｋ−３の阻害剤として有用なヘテロアリール化合物
|
|
US20040009981A1
(en)
|
2002-03-15 |
2004-01-15 |
David Bebbington |
Compositions useful as inhibitors of protein kinases
|
|
ATE433973T1
(de)
*
|
2002-03-15 |
2009-07-15 |
Vertex Pharma |
Azolylaminoazine als inhibitoren von proteinkinasen
|
|
EP1485100B1
(en)
|
2002-03-15 |
2010-05-05 |
Vertex Pharmaceuticals Incorporated |
Azinylaminoazoles as inhibitors of protein kinases
|
|
IL163737A0
(en)
*
|
2002-04-05 |
2005-12-18 |
Boehringer Ingelheim Pharma |
Method of treating mucus hypersecretion
|
|
ES2340475T3
(es)
*
|
2002-05-01 |
2010-06-04 |
Vertex Pharmaceuticals Incorporated |
Estructura cristalizada de proteina aurora-2 y sus bolsillos de union.
|
|
AU2003247425B2
(en)
*
|
2002-05-22 |
2007-03-08 |
Amgen Inc. |
Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain
|
|
WO2003104230A1
(ja)
*
|
2002-06-07 |
2003-12-18 |
協和醱酵工業株式会社 |
二環性ピリミジン誘導体
|
|
AU2003251721A1
(en)
|
2002-06-14 |
2003-12-31 |
Laboratoires Serono Sa |
Azole methylidene cyanide derivatives and their use as protein kinase modulators
|
|
MY141867A
(en)
*
|
2002-06-20 |
2010-07-16 |
Vertex Pharma |
Substituted pyrimidines useful as protein kinase inhibitors
|
|
US7015227B2
(en)
|
2002-06-21 |
2006-03-21 |
Cgi Pharmaceuticals, Inc. |
Certain amino-substituted monocycles as kinase modulators
|
|
CA2492673A1
(en)
*
|
2002-07-17 |
2004-01-22 |
Pharmacia Italia S.P.A. |
Heterobicyclic pyrazole derivatives as kinase inhibitors
|
|
AU2003256783A1
(en)
*
|
2002-07-25 |
2004-02-16 |
Scios, Inc. |
METHODS FOR IMPROVEMENT OF LUNG FUNCTION USING TGF-Beta INHIBITORS
|
|
JP2006514989A
(ja)
|
2002-07-29 |
2006-05-18 |
ライジェル ファーマシューティカルズ |
２，４−ピリミジンジアミン化合物による自己免疫疾患の治療および予防方法
|
|
NZ538426A
(en)
*
|
2002-08-02 |
2007-05-31 |
Vertex Pharma |
Pyrazole compositions useful as inhibitors of glycogen synthase kinase-3 (GSK-3)
|
|
SI1532145T1
(sl)
*
|
2002-08-02 |
2007-02-28 |
Vertex Pharma |
Pirazolni sestavki, koristni kot inhibitorji GSK-3
|
|
JP2006507237A
(ja)
*
|
2002-08-13 |
2006-03-02 |
メルク シャープ エンド ドーム リミテッド |
Ｇａｂａ受容体に対するリガンドとしてのフェニルピリダジン誘導体
|
|
KR20050042478A
(ko)
|
2002-08-14 |
2005-05-09 |
버텍스 파마슈티칼스 인코포레이티드 |
프로테인 키나아제 억제제 및 이의 용도
|
|
FR2844267B1
(fr)
*
|
2002-09-05 |
2008-02-15 |
Aventis Pharma Sa |
Nouveaux derives d'aminoindazoles a titre de medicaments et compositions pharmaceutiques les renfermant
|
|
BR0314098A
(pt)
*
|
2002-09-05 |
2005-07-19 |
Aventis Pharma Sa |
Derivados da aminoindazóis a tìtulo de medicamentos e composições farmacêuticas que os contêm
|
|
UA80295C2
(en)
|
2002-09-06 |
2007-09-10 |
Biogen Inc |
Pyrazolopyridines and using the same
|
|
CN1694708A
(zh)
*
|
2002-09-10 |
2005-11-09 |
西奥斯股份有限公司 |
TGFβ的抑制剂
|
|
AU2003286876A1
(en)
|
2002-11-01 |
2004-06-07 |
Vertex Pharmaceuticals Incorporated |
Compositions useful as inhibitors of jak and other protein kinases
|
|
US7348335B2
(en)
|
2002-11-05 |
2008-03-25 |
Vertex Pharmaceuticals Incorporated |
Compositions useful as inhibitors of JAK and other protein kinases
|
|
CA2507100C
(en)
|
2002-11-21 |
2012-10-09 |
Chiron Corporation |
2,4,6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer
|
|
SI2316831T1
(sl)
*
|
2002-11-21 |
2013-07-31 |
Novartis Ag |
2-(morfolin-4-il)pirimidini kot inhibitorji fosfotidilinozitol (PI) 3-kinaze in njihova uporaba pri zdravljenju raka
|
|
AU2003288994A1
(en)
*
|
2002-12-10 |
2004-06-30 |
Ono Pharmaceutical Co., Ltd. |
Nitrogen-containing heterocyclic compounds and medicinal use thereof
|
|
FR2848554A1
(fr)
*
|
2002-12-12 |
2004-06-18 |
Aventis Pharma Sa |
Nouveaux derives d'aminoindazoles a titre de medicaments et compositions pharmaceutiques les renfermant
|
|
RU2339624C2
(ru)
|
2002-12-12 |
2008-11-27 |
Авентис Фарма С.А. |
Производные аминоиндазолов и их применение в качестве ингибиторов киназ
|
|
CA2509233A1
(en)
|
2002-12-13 |
2004-07-01 |
Neurogen Corporation |
2-substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators
|
|
US7601718B2
(en)
|
2003-02-06 |
2009-10-13 |
Vertex Pharmaceuticals Incorporated |
Compositions useful as inhibitors of protein kinases
|
|
US7157455B2
(en)
*
|
2003-02-10 |
2007-01-02 |
Hoffmann-La Roche Inc. |
4-Aminopyrimidine-5-one derivatives
|
|
CA2520465A1
(en)
*
|
2003-03-28 |
2004-10-14 |
Scios Inc. |
Bi-cyclic pyrimidine inhibitors of tgf.beta.
|
|
EP1610774A4
(en)
*
|
2003-04-09 |
2008-07-16 |
Exelixis Inc |
TIE-2 MODULATORS AND METHODS OF USE
|
|
JP2006524254A
(ja)
*
|
2003-04-24 |
2006-10-26 |
メルク エンド カムパニー インコーポレーテッド |
Ａｋｔ活性の阻害剤
|
|
WO2004096808A1
(en)
*
|
2003-04-28 |
2004-11-11 |
De Novo Pharmaceuticals Limited |
Triazine compounds and their use
|
|
CA2528834A1
(en)
*
|
2003-06-13 |
2005-02-10 |
Arena Pharmaceuticals, Inc. |
5-substituted 2h-pyrazole-3-carboxylic acid derivatives as agonists for the nicotinic acid receptor rup25 for the treatment of dyslipidemia and related diseases
|
|
AU2004257149A1
(en)
*
|
2003-06-20 |
2005-01-27 |
Coley Pharmaceutical Gmbh |
Small molecule toll-like receptor (TLR) antagonists
|
|
TW200510373A
(en)
|
2003-07-14 |
2005-03-16 |
Neurogen Corp |
Substituted quinolin-4-ylamine analogues
|
|
US7329664B2
(en)
|
2003-07-16 |
2008-02-12 |
Neurogen Corporation |
Substituted (7-pyridyl-4-phenylamino-quinazolin-2-yl)-methanol analogues
|
|
WO2005012256A1
(en)
|
2003-07-22 |
2005-02-10 |
Astex Therapeutics Limited |
3, 4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinases (cdk) and glycogen synthase kinase-3 (gsk-3) modulators
|
|
GB0317127D0
(en)
*
|
2003-07-22 |
2003-08-27 |
Astex Technology Ltd |
Pharmaceutical compounds
|
|
KR20120062863A
(ko)
|
2003-07-30 |
2012-06-14 |
리겔 파마슈티칼스, 인크. |
자가면역 질환의 치료 또는 예방에 사용하기 위한 2,4-피리미딘디아민 화합물
|
|
TW200521119A
(en)
*
|
2003-08-05 |
2005-07-01 |
Vertex Pharma |
Compositions useful as inhibitors of voltage-gated ion channels
|
|
DE602004025258D1
(de)
*
|
2003-08-06 |
2010-03-11 |
Vertex Pharma |
Aminotriazol-verbindungen als proteinkinase-hemmer
|
|
EP1668013B1
(en)
*
|
2003-09-23 |
2012-02-22 |
Vertex Pharmaceuticals Incorporated |
Pyrazolopyrrole derivatives as protein kinase inhibitors
|
|
GB0323137D0
(en)
|
2003-10-03 |
2003-11-05 |
Chang Lisa C W |
2,4,6- Trisubstituted pyrimidines and their different uses
|
|
CA2542522A1
(en)
|
2003-10-17 |
2005-05-06 |
Astrazeneca Ab |
4-(pyrazol-3-ylamino) pyrimidine derivatives for use in the treatment of cancer
|
|
US8455489B2
(en)
*
|
2003-11-10 |
2013-06-04 |
Exelixis, Inc. |
Substituted pyrimidine compositions and methods of use
|
|
TW200528106A
(en)
|
2003-11-10 |
2005-09-01 |
Synta Pharmaceuticals Corp |
Pyridine compounds
|
|
KR101206843B1
(ko)
|
2003-12-03 |
2012-11-30 |
와이엠 바이오사이언시즈 오스트레일리아 피티와이 엘티디 |
튜불린 저해제
|
|
AU2004297235A1
(en)
*
|
2003-12-04 |
2005-06-23 |
Vertex Pharmaceuticals Incorporated |
Quinoxalines useful as inhibitors of protein kinases
|
|
JP2007513955A
(ja)
*
|
2003-12-09 |
2007-05-31 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
ナフチリジン誘導体およびそれらのムスカリン受容体の調節剤としての使用
|
|
JP2007514759A
(ja)
|
2003-12-19 |
2007-06-07 |
タケダ サン ディエゴ インコーポレイテッド |
キナーゼ阻害剤
|
|
TW200530235A
(en)
|
2003-12-24 |
2005-09-16 |
Renovis Inc |
Bicycloheteroarylamine compounds as ion channel ligands and uses thereof
|
|
US7435823B2
(en)
|
2004-01-23 |
2008-10-14 |
Amgen Inc. |
Compounds and methods of use
|
|
CA2553433A1
(en)
|
2004-01-23 |
2005-08-11 |
Amgen Inc. |
Quinoline quinazoline pyridine and pyrimidine compounds and their use in the treatment of inflammation angiogenesis and cancer
|
|
AU2005212438A1
(en)
*
|
2004-02-11 |
2005-08-25 |
Amgen Inc. |
Vanilloid receptor ligands and their use in treatments
|
|
EP1809614B1
(en)
|
2004-04-08 |
2014-05-07 |
TargeGen, Inc. |
Benzotriazine inhibitors of kinases
|
|
CA2561718A1
(en)
|
2004-04-13 |
2005-10-27 |
Icagen, Inc. |
Polycyclic pyridines as potassium ion channel modulators
|
|
US20050250829A1
(en)
*
|
2004-04-23 |
2005-11-10 |
Takeda San Diego, Inc. |
Kinase inhibitors
|
|
US7793137B2
(en)
|
2004-10-07 |
2010-09-07 |
Cisco Technology, Inc. |
Redundant power and data in a wired data telecommunincations network
|
|
AU2005243175B2
(en)
*
|
2004-05-14 |
2011-12-01 |
Millennium Pharmaceuticals, Inc. |
Compounds and methods for inhibiting mitotic progression by inhibition of Aurora kinase
|
|
EP1598348A1
(en)
|
2004-05-18 |
2005-11-23 |
Aventis Pharma Deutschland GmbH |
Novel pyridazinone derivatives as inhibitors of CDK2
|
|
EP1604988A1
(en)
*
|
2004-05-18 |
2005-12-14 |
Sanofi-Aventis Deutschland GmbH |
Pyridazinone derivatives, methods for producing them and their use as pharmaceuticals
|
|
DE102004028862A1
(de)
*
|
2004-06-15 |
2005-12-29 |
Merck Patent Gmbh |
3-Aminoindazole
|
|
GB0415364D0
(en)
*
|
2004-07-09 |
2004-08-11 |
Astrazeneca Ab |
Pyrimidine derivatives
|
|
US20080261821A1
(en)
*
|
2004-07-21 |
2008-10-23 |
The Regents Of Te University Of California |
Mechanism-Based Crosslinkers
|
|
JP2008510734A
(ja)
|
2004-08-18 |
2008-04-10 |
タケダ サン ディエゴ インコーポレイテッド |
キナーゼ阻害剤
|
|
JP5006194B2
(ja)
|
2004-08-19 |
2012-08-22 |
ディーエスエム アイピー アセッツ ビー．ブイ． |
高沸点の空気および／または温度感受性有用生成物の混合物の精留方法
|
|
GB0419416D0
(en)
|
2004-09-01 |
2004-10-06 |
Inst Of Ex Botany Ascr |
4-Arylazo-3,5-Diamino-Pyrazole compounds and use thereof
|
|
AU2005284904A1
(en)
|
2004-09-13 |
2006-03-23 |
Amgen Inc. |
Vanilloid receptor ligands and their use in treatments
|
|
US7622486B2
(en)
*
|
2004-09-23 |
2009-11-24 |
Reddy Us Therapeutics, Inc. |
Pyridine compounds, process for their preparation and compositions containing them
|
|
US7285569B2
(en)
|
2004-09-24 |
2007-10-23 |
Hoff Hoffmann-La Roche Inc. |
Tricycles, their manufacture and use as pharmaceutical agents
|
|
TW200624431A
(en)
|
2004-09-24 |
2006-07-16 |
Hoffmann La Roche |
Phthalazinone derivatives, their manufacture and use as pharmaceutical agents
|
|
AR052771A1
(es)
|
2004-09-30 |
2007-04-04 |
Tibotec Pharm Ltd |
Pirimidinas biciclicas inhibidoras del vhc
|
|
TW200621251A
(en)
|
2004-10-12 |
2006-07-01 |
Neurogen Corp |
Substituted biaryl quinolin-4-ylamine analogues
|
|
EP1812439B2
(en)
|
2004-10-15 |
2017-12-06 |
Takeda Pharmaceutical Company Limited |
Kinase inhibitors
|
|
TW200621257A
(en)
|
2004-10-20 |
2006-07-01 |
Astellas Pharma Inc |
Pyrimidine derivative fused with nonaromatic ring
|
|
WO2006050359A2
(en)
|
2004-11-02 |
2006-05-11 |
Northwestern University |
Pyridazine compounds and methods
|
|
EP2592075B1
(en)
|
2004-11-02 |
2015-04-29 |
Northwestern University |
Pyridazine compounds for the treatment of inflammatory diseases
|
|
CA2587427A1
(en)
*
|
2004-11-17 |
2006-05-26 |
Miikana Therapeutics, Inc. |
Kinase inhibitors
|
|
WO2006068770A1
(en)
|
2004-11-24 |
2006-06-29 |
Rigel Pharmaceuticals, Inc. |
Spiro-2, 4-pyrimidinediamine compounds and their uses
|
|
EP1827434B1
(en)
|
2004-11-30 |
2014-01-15 |
Amgen Inc. |
Quinolines and quinazoline analogs and their use as medicaments for treating cancer
|
|
US20060128710A1
(en)
*
|
2004-12-09 |
2006-06-15 |
Chih-Hung Lee |
Antagonists to the vanilloid receptor subtype 1 (VR1) and uses thereof
|
|
EP1831216A2
(en)
*
|
2004-12-23 |
2007-09-12 |
Pfizer Products Inc. |
Heteroaromatic derivatives useful as anticancer agents
|
|
JP5208516B2
(ja)
*
|
2004-12-30 |
2013-06-12 |
エグゼリクシス， インコーポレイテッド |
キナーゼモジュレーターとしてのピリミジン誘導体および使用方法
|
|
DK1856135T3
(da)
|
2005-01-19 |
2010-04-12 |
Rigel Pharmaceuticals Inc |
Prodrugs af 2,4-pyrimidindiamin-forbindelser og deres anvendelser
|
|
AR054425A1
(es)
|
2005-01-21 |
2007-06-27 |
Astex Therapeutics Ltd |
Sales de adicion de piperidin 4-il- amida de acido 4-(2,6-dicloro-benzoilamino) 1h-pirazol-3-carboxilico.
|
|
US8404718B2
(en)
|
2005-01-21 |
2013-03-26 |
Astex Therapeutics Limited |
Combinations of pyrazole kinase inhibitors
|
|
JP4804480B2
(ja)
*
|
2005-01-26 |
2011-11-02 |
シェーリング コーポレイション |
癌の処置のためのプロテインキナーゼインヒビターとしての、３−（インダゾール−５−イル）−（１，２，４）トリアジン誘導体、および関連する化合物
|
|
SI1846394T1
(sl)
|
2005-02-04 |
2012-06-29 |
Astrazeneca Ab |
Pirazolilaminopiridinski derivati uporabni kot kinazni inhibitorji
|
|
US20060178388A1
(en)
|
2005-02-04 |
2006-08-10 |
Wrobleski Stephen T |
Phenyl-substituted pyrimidine compounds useful as kinase inhibitors
|
|
RU2405780C2
(ru)
|
2005-02-16 |
2010-12-10 |
Астразенека Аб |
Химические соединения
|
|
JP2008534481A
(ja)
*
|
2005-03-23 |
2008-08-28 |
アストラゼネカ アクチボラグ |
インスリン様増殖因子−１受容体活性の阻害剤としての２−アゼチジニル−４−（１ｈ−ピラゾール−３−イルアミノ）ピリミジン
|
|
US7402596B2
(en)
|
2005-03-24 |
2008-07-22 |
Renovis, Inc. |
Bicycloheteroaryl compounds as P2X7 modulators and uses thereof
|
|
AU2006226322B2
(en)
|
2005-03-25 |
2012-03-29 |
Tibotec Pharmaceuticals Ltd. |
Heterobicylic inhibitors of HCV
|
|
MX2007012345A
(es)
*
|
2005-04-05 |
2007-11-23 |
Astrazeneca Ab |
Derivados de pirimidina para uso como agentes anticancer.
|
|
GB0507347D0
(en)
*
|
2005-04-12 |
2005-05-18 |
Astrazeneca Ab |
Chemical compounds
|
|
AU2006233537A1
(en)
|
2005-04-14 |
2006-10-19 |
F. Hoffmann-La Roche Ag |
Aminopyrazole derivatives, their manufacture and use as pharmaceutical agents
|
|
JO2787B1
(en)
|
2005-04-27 |
2014-03-15 |
امجين إنك, |
Alternative amide derivatives and methods of use
|
|
JP5075624B2
(ja)
|
2005-04-28 |
2012-11-21 |
田辺三菱製薬株式会社 |
シアノピリジン誘導体及びその医薬としての用途
|
|
EP1885369B1
(en)
*
|
2005-05-04 |
2015-09-23 |
Evotec AG |
Fused heterocyclic compounds, and compositions and uses thereof
|
|
EP1885454A2
(en)
|
2005-05-04 |
2008-02-13 |
DeveloGen Aktiengesellschaft |
Use of gsk-3 inhibitors for preventing and treating pancreatic autoimmune disorders
|
|
WO2006117560A1
(en)
*
|
2005-05-05 |
2006-11-09 |
Astrazeneca Ab |
Pyrazolyl-amino- substituted pyrimidines and their use in the treatment of cancer
|
|
AR056347A1
(es)
|
2005-05-12 |
2007-10-03 |
Tibotec Pharm Ltd |
Uso de compuestos de pteridina para fabricar medicamentos y composiciones farmaceuticas
|
|
WO2006123113A2
(en)
*
|
2005-05-16 |
2006-11-23 |
Astrazeneca Ab |
Pyrazolylaminopyrimidine derivatives useful as tyrosine kinase inhibitors
|
|
EP1899332A1
(en)
|
2005-06-24 |
2008-03-19 |
Gilead Sciences, Inc. |
Pyrido(3,2-d)pyrimidines and pharmaceutical compositions useful for treating hepatitis c.
|
|
ES2270715B1
(es)
|
2005-07-29 |
2008-04-01 |
Laboratorios Almirall S.A. |
Nuevos derivados de pirazina.
|
|
EP1917259B1
(en)
*
|
2005-08-18 |
2012-01-25 |
Vertex Pharmaceuticals Incorporated |
Pyrazine kinase inhibitors
|
|
WO2007023382A2
(en)
*
|
2005-08-25 |
2007-03-01 |
Pfizer Inc. |
Pyrimidine amino pyrazole compounds, potent kinase inhibitors
|
|
EP2258358A3
(en)
|
2005-08-26 |
2011-09-07 |
Braincells, Inc. |
Neurogenesis with acetylcholinesterase inhibitor
|
|
JP2009506069A
(ja)
|
2005-08-26 |
2009-02-12 |
ブレインセルス，インコーポレイティド |
ムスカリン性受容体調節による神経発生
|
|
EP1934219A1
(en)
|
2005-09-16 |
2008-06-25 |
Ranbaxy Laboratories Limited |
Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
|
|
UA96427C2
(en)
*
|
2005-09-30 |
2011-11-10 |
Мийкана Терапьютикс, Инк. |
Substituted pyrazole compounds
|
|
JP5597353B2
(ja)
*
|
2005-09-30 |
2014-10-01 |
ミイカナ セラピューティクス インコーポレイテッド |
置換ピラゾール化合物
|
|
ES2274712B1
(es)
|
2005-10-06 |
2008-03-01 |
Laboratorios Almirall S.A. |
Nuevos derivados imidazopiridina.
|
|
US8119655B2
(en)
|
2005-10-07 |
2012-02-21 |
Takeda Pharmaceutical Company Limited |
Kinase inhibitors
|
|
GB0520657D0
(en)
*
|
2005-10-11 |
2005-11-16 |
Ludwig Inst Cancer Res |
Pharmaceutical compounds
|
|
CA2625153A1
(en)
|
2005-10-21 |
2007-04-26 |
Braincells, Inc. |
Modulation of neurogenesis by pde inhibition
|
|
WO2007049041A1
(en)
|
2005-10-28 |
2007-05-03 |
Astrazeneca Ab |
4- (3-aminopyrazole) pyrimidine derivatives for use as tyrosine kinase inhibitors in the treatment of cancer
|
|
CA2625210A1
(en)
|
2005-10-31 |
2007-05-10 |
Braincells, Inc. |
Gaba receptor mediated modulation of neurogenesis
|
|
MX391408B
(es)
|
2005-11-01 |
2025-03-21 |
Impact Biomedicines Inc |
Inhibidores de biaril meta-pirimidina de cinasas.
|
|
JP5249770B2
(ja)
*
|
2005-11-03 |
2013-07-31 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
キナーゼインヒビターとして有用なアミノピリジン
|
|
DK1945632T3
(da)
|
2005-11-08 |
2013-12-16 |
Vertex Pharma |
Heterocycliske modulatorer af ATP-bindende kassettetransportører
|
|
US7713987B2
(en)
|
2005-12-06 |
2010-05-11 |
Rigel Pharmaceuticals, Inc. |
Pyrimidine-2,4-diamines and their uses
|
|
US8546404B2
(en)
|
2005-12-13 |
2013-10-01 |
Merck Sharp & Dohme |
Compounds that are ERK inhibitors
|
|
US7572809B2
(en)
|
2005-12-19 |
2009-08-11 |
Hoffmann-La Roche Inc. |
Isoquinoline aminopyrazole derivatives
|
|
CA2633584A1
(en)
*
|
2005-12-20 |
2007-07-05 |
Takeda Pharmaceutical Company Limited |
Glucokinase activators
|
|
RU2453548C2
(ru)
|
2006-01-17 |
2012-06-20 |
Вертекс Фармасьютикалз Инкорпорейтед |
Азаиндолы, полезные в качестве ингибиторов янус-киназ
|
|
JO2660B1
(en)
|
2006-01-20 |
2012-06-17 |
نوفارتيس ايه جي |
Pi-3 inhibitors and methods of use
|
|
ATE485268T1
(de)
|
2006-02-16 |
2010-11-15 |
Schering Corp |
Pyrrolidin-derivate als erk-hemmer
|
|
WO2007104035A1
(en)
*
|
2006-03-08 |
2007-09-13 |
Braincells, Inc. |
Modulation of neurogenesis by nootropic agents
|
|
US20100216734A1
(en)
|
2006-03-08 |
2010-08-26 |
Braincells, Inc. |
Modulation of neurogenesis by nootropic agents
|
|
PE20080145A1
(es)
|
2006-03-21 |
2008-02-11 |
Janssen Pharmaceutica Nv |
Tetrahidro-pirimidoazepinas como moduladores de trpv1
|
|
EP2007732B1
(en)
*
|
2006-04-11 |
2011-11-23 |
Vertex Pharmaceuticals, Inc. |
Thiazoles, imidazoles, and pyrazoles useful as inhibitors of protein kinases
|
|
CA2650711A1
(en)
|
2006-04-28 |
2007-11-08 |
Northwestern University |
Compositions and treatments using pyridazine compounds and cholinesterase inhibitors
|
|
MX2008014320A
(es)
|
2006-05-09 |
2009-03-25 |
Braincells Inc |
Neurogenesis mediada por el receptor de 5-hidroxitriptamina.
|
|
US20100009983A1
(en)
*
|
2006-05-09 |
2010-01-14 |
Braincells, Inc. |
5 ht receptor mediated neurogenesis
|
|
EP2382975A3
(en)
|
2006-05-09 |
2012-02-29 |
Braincells, Inc. |
Neurogenesis by modulating angiotensin
|
|
RS53230B
(sr)
|
2006-06-27 |
2014-08-29 |
Takeda Pharmaceutical Company Limited |
Kondenzovana ciklična jedinjenja kao modulatori gpr40 receptora
|
|
AU2007263655A1
(en)
*
|
2006-06-30 |
2008-01-03 |
Astrazeneca Ab |
Pyrimidine derivatives useful in the treatment of cancer
|
|
CA2656290A1
(en)
*
|
2006-07-05 |
2008-01-10 |
Exelixis, Inc. |
Methods of using igf1r and abl kinase modulators
|
|
US8063050B2
(en)
|
2006-07-06 |
2011-11-22 |
Array Biopharma Inc. |
Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors
|
|
UA95641C2
(xx)
*
|
2006-07-06 |
2011-08-25 |
Эррей Биофарма Инк. |
Гідроксильовані піримідильні циклопентани як інгібітори акт протеїнкінази$гидроксилированные пиримидильные циклопентаны как ингибиторы акт протеинкиназы
|
|
SI2049500T1
(sl)
*
|
2006-07-06 |
2012-01-31 |
Array Biopharma Inc |
Ciklopenta (d) pirimidini kot AKT protein kinazni inhibitorji
|
|
US8338435B2
(en)
|
2006-07-20 |
2012-12-25 |
Gilead Sciences, Inc. |
Substituted pyrido(3,2-D) pyrimidines and pharmaceutical compositions for treating viral infections
|
|
JP2010502722A
(ja)
|
2006-09-08 |
2010-01-28 |
ブレインセルス，インコーポレイティド |
４−アシルアミノピリジン誘導体を含む組み合わせ
|
|
US20100184806A1
(en)
|
2006-09-19 |
2010-07-22 |
Braincells, Inc. |
Modulation of neurogenesis by ppar agents
|
|
US20080103165A1
(en)
*
|
2006-09-19 |
2008-05-01 |
Braincells, Inc. |
Ppar mediated modulation of neurogenesis
|
|
EP2223925A1
(en)
*
|
2006-10-09 |
2010-09-01 |
Takeda Pharmaceutical Company Limited |
Kinase inhibitors
|
|
JP2010505962A
(ja)
|
2006-10-09 |
2010-02-25 |
武田薬品工業株式会社 |
キナーゼ阻害剤
|
|
ES2445791T3
(es)
*
|
2006-10-21 |
2014-03-05 |
Abbvie Deutschland Gmbh & Co Kg |
Compuestos hetererocíclicos y su uso como inhibidores de la glucógeno sintasa cinasa 3
|
|
JP2010509231A
(ja)
*
|
2006-11-02 |
2010-03-25 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
プロテインキナーゼの阻害剤として有用なアミノピリジンおよびアミノピリミジン
|
|
NZ577768A
(en)
*
|
2006-12-19 |
2012-01-12 |
Vertex Pharma |
Aminopyrimidines useful as inhibitors of protein kinases
|
|
WO2008077649A1
(en)
|
2006-12-26 |
2008-07-03 |
Gilead Sciences, Inc. |
Pyrido(3,2-d)pyrimidines useful for treating viral infectons
|
|
TW200840584A
(en)
|
2006-12-26 |
2008-10-16 |
Gilead Sciences Inc |
Pyrido(3,2-d)pyrimidines useful for treating viral infections
|
|
WO2008077650A1
(en)
|
2006-12-26 |
2008-07-03 |
Gilead Sciences, Inc. |
Pyrido(3,2-d)pyrimidines useful for treating viral infections
|
|
EA200901065A1
(ru)
|
2007-02-06 |
2010-02-26 |
Новартис Аг |
Ингибиторы pi 3-киназы и способы их применения
|
|
JP2010518083A
(ja)
*
|
2007-02-12 |
2010-05-27 |
メルク・シャープ・エンド・ドーム・コーポレイション |
ピペリジン誘導体
|
|
JP2010518064A
(ja)
*
|
2007-02-12 |
2010-05-27 |
メルク・シャープ・エンド・ドーム・コーポレイション |
Ａｄおよび関連状態の治療のためのピペラジン誘導体
|
|
WO2008111441A1
(ja)
|
2007-03-05 |
2008-09-18 |
Kyowa Hakko Kirin Co., Ltd. |
医薬組成物
|
|
MX2009009590A
(es)
*
|
2007-03-09 |
2009-11-10 |
Vertex Pharma |
Aminopirimidinas utiles como inhibidores de proteinas cinasas.
|
|
ES2374335T3
(es)
*
|
2007-03-09 |
2012-02-15 |
Vertex Pharmaceuticals Incorporated |
Aminopirimidinas útiles como inhibidores de proteína quinasas.
|
|
AU2008226461A1
(en)
|
2007-03-09 |
2008-09-18 |
Vertex Pharmaceuticals Incorporated |
Aminopyridines useful as inhibitors of protein kinases
|
|
CN101679386A
(zh)
|
2007-04-13 |
2010-03-24 |
沃泰克斯药物股份有限公司 |
可用作激酶抑制剂的氨基嘧啶类化合物
|
|
EP2155742A1
(en)
*
|
2007-04-18 |
2010-02-24 |
AstraZeneca AB |
5-aminopyrazol-3-yl-3h-imidazo [4,5-b]pyridine derivatives and their use for the treatment of cancer
|
|
MX2009011811A
(es)
*
|
2007-05-02 |
2010-01-14 |
Vertex Pharma |
Aminopirimidinas utiles como inhibidores de cinasa.
|
|
MX2009011810A
(es)
*
|
2007-05-02 |
2010-01-14 |
Vertex Pharma |
Tiazoles y pirazoles utiles como inhibidores de cinasa.
|
|
MX2009011812A
(es)
*
|
2007-05-02 |
2010-01-14 |
Vertex Pharma |
Aminopirimidinas utiles como inhibidores de cinasa.
|
|
JP2010526048A
(ja)
*
|
2007-05-04 |
2010-07-29 |
アストラゼネカ アクチボラグ |
アミノ−チアゾリル−ピリミジン誘導体、および癌の治療のための該誘導体の使用
|
|
UA99459C2
(en)
*
|
2007-05-04 |
2012-08-27 |
Астразенека Аб |
9-(pyrazol-3-yl)- 9h-purine-2-amine and 3-(pyraz0l-3-yl)-3h-imidazo[4,5-b]pyridin-5-amine derivatives and their use for the treatment of cancer
|
|
EP2789606B1
(en)
|
2007-05-09 |
2017-11-15 |
Vertex Pharmaceuticals Incorporated |
Modulators of CFTR
|
|
CN101687852A
(zh)
*
|
2007-05-24 |
2010-03-31 |
沃泰克斯药物股份有限公司 |
可用作激酶抑制剂的噻唑类和吡唑类化合物
|
|
US20090029992A1
(en)
*
|
2007-06-11 |
2009-01-29 |
Agoston Gregory E |
Substituted pyrazole compounds
|
|
WO2008156580A1
(en)
*
|
2007-06-13 |
2008-12-24 |
Merck & Co., Inc. |
Triazole derivatives for treating alzheimer's disease and related conditions
|
|
JP2010531316A
(ja)
|
2007-06-25 |
2010-09-24 |
エフ．ホフマン−ラ ロシュ アーゲー |
キナーゼ阻害剤としてのベンズイミダゾールアミド誘導体
|
|
US8846683B2
(en)
|
2007-07-05 |
2014-09-30 |
Array Biopharma, Inc. |
Pyrimidyl cyclopentanes as Akt protein kinase inhibitors
|
|
US9409886B2
(en)
|
2007-07-05 |
2016-08-09 |
Array Biopharma Inc. |
Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
|
|
ATE522509T1
(de)
*
|
2007-07-05 |
2011-09-15 |
Array Biopharma Inc |
Pyrimidylcyclopentane als inhibitoren der akt- proteinkinase
|
|
ES2551352T3
(es)
*
|
2007-07-05 |
2015-11-18 |
Array Biopharma, Inc. |
Pirimido ciclopentanos útiles para el tratamiento de enfermedades inflamatorias o hiperproliferativas
|
|
ES2392003T3
(es)
|
2007-07-25 |
2012-12-03 |
Bristol-Myers Squibb Company |
Inhibidores de la triazina quinasa
|
|
CA2694499A1
(en)
*
|
2007-07-31 |
2009-02-05 |
Vertex Pharmaceuticals Incorporated |
Process for preparing 5-fluoro-1h-pyrazolo [3, 4-b] pyridin-3-amine and derivatives thereof
|
|
TW200906818A
(en)
*
|
2007-07-31 |
2009-02-16 |
Astrazeneca Ab |
Chemical compounds
|
|
EP2222661B1
(en)
*
|
2007-11-20 |
2016-04-20 |
Merck Sharp & Dohme Corp. |
Non-nucleoside reverse transcriptase inhibitors
|
|
KR20160040745A
(ko)
|
2007-12-07 |
2016-04-14 |
버텍스 파마슈티칼스 인코포레이티드 |
3-(6-(1-(2,2-디플루오로벤조[ｄ][1,3]디옥솔-5-일)사이클로프로판카복스아미도)-3-메틸피리딘-2-일)벤조산의 고체 형태
|
|
ES2604555T3
(es)
*
|
2007-12-07 |
2017-03-07 |
Vertex Pharmaceuticals Incorporated |
Procedimiento para producir ácidos cicloalquilcarboxiamido-piridinabenzoicos
|
|
JP2011032169A
(ja)
*
|
2007-12-11 |
2011-02-17 |
Genecare Research Institute Co Ltd |
４−アミノピリミジン誘導体および該化合物を含有する医薬組成物
|
|
PE20091102A1
(es)
|
2007-12-17 |
2009-07-25 |
Janssen Pharmaceutica Nv |
Moduladores imidazolo-, oxazolo-, y tiazolopirimidina del trpv1
|
|
JP5635910B2
(ja)
*
|
2008-01-09 |
2014-12-03 |
アレイ バイオファーマ、インコーポレイテッド |
ＡＫＴタンパク質キナーゼ阻害剤としての５Ｈ−シクロペンタ［ｄ］ピリミジン
|
|
CN102015708B
(zh)
*
|
2008-01-09 |
2014-03-26 |
阵列生物制药公司 |
作为akt蛋白激酶抑制剂的嘧啶基环戊烷
|
|
NZ587504A
(en)
|
2008-02-21 |
2012-09-28 |
Merck Sharp & Dohme |
Benzopyrazole derivatives as ERK inhibitors
|
|
NZ720282A
(en)
|
2008-02-28 |
2017-12-22 |
Vertex Pharma |
Heteroaryl derivatives as cftr modulators
|
|
WO2009145814A2
(en)
*
|
2008-03-10 |
2009-12-03 |
Vertex Pharmaceuticals Incorporated |
Pyrimidines and pyridines useful as inhibitors of protein kinases
|
|
CL2009000904A1
(es)
*
|
2008-04-21 |
2010-04-30 |
Shionogi & Co |
Compuestos derivados de ciclohexil sulfonamidas que tienen actividad antagonista en el receptor npy y5, composicion farmaceutica y formulacion farmaceutica que los comprende.
|
|
US8158656B2
(en)
*
|
2008-05-16 |
2012-04-17 |
Shenzhen Chipscreen Biosciences Ltd. |
2-indolinone derivatives as multi-target protein kinase inhibitors and histone deacetylase inhibitors
|
|
KR101860057B1
(ko)
|
2008-05-21 |
2018-05-21 |
어리어드 파마슈티칼스, 인코포레이티드 |
키나아제 억제제로서 포스포러스 유도체
|
|
UY31885A
(es)
*
|
2008-06-11 |
2010-01-29 |
Astrazeneca Ab |
Derivados de las 1, 3, 5-triazina-2, 4-diaminas-6-sustituidas-n-sustituidas y sales farmacéuticamente aceptables de los mismos, composiciones y aplicaciones.
|
|
MY158927A
(en)
|
2008-06-12 |
2016-11-30 |
Janssen Pharmaceutica Nv |
Diamino-pyridine, pyrimidine, and pyridazine modulators of the histamine h4 receptor
|
|
WO2010002998A1
(en)
|
2008-07-03 |
2010-01-07 |
Gilead Sciences, Inc. |
2,4,6-TRISUBSTITUTED PYRIDO (3,2-d) PYRIMIDINES USEFUL FOR TREATING VIRAL INFECTIONS
|
|
WO2010002779A2
(en)
*
|
2008-07-03 |
2010-01-07 |
Merck Serono S.A. |
Naphthyridininones as aurora kinase inhibitors
|
|
WO2010014939A1
(en)
|
2008-07-31 |
2010-02-04 |
Genentech, Inc. |
Pyrimidine compounds, compositions and methods of use
|
|
WO2010019392A1
(en)
*
|
2008-08-13 |
2010-02-18 |
Merck Sharp & Dohme Corp. |
Purine derivatives for treatment of alzheimer's disease
|
|
JP2012501971A
(ja)
*
|
2008-09-03 |
2012-01-26 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
共結晶および共結晶を含む薬学的処方物
|
|
EP2340248B1
(en)
*
|
2008-09-15 |
2017-05-31 |
The Regents of The University of California |
Methods and compositions for modulating ire1, src, and abl activity
|
|
EP2346859A1
(en)
*
|
2008-09-30 |
2011-07-27 |
AstraZeneca AB |
Heterocyclic jak kinase inhibitors
|
|
US20110257208A1
(en)
*
|
2008-11-19 |
2011-10-20 |
Matthew Duncton |
Compounds useful as faah modulators and uses thereof
|
|
KR101048448B1
(ko)
|
2008-11-21 |
2011-07-11 |
한국화학연구원 |
신규 피라졸로[4,3-ｂ]피리딘 유도체 또는 이의 약학적으로허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 약학적 조성물
|
|
KR101730665B1
(ko)
|
2009-02-05 |
2017-04-26 |
다케다 야쿠힌 고교 가부시키가이샤 |
피리다지논 화합물
|
|
WO2010099217A1
(en)
|
2009-02-25 |
2010-09-02 |
Braincells, Inc. |
Modulation of neurogenesis using d-cycloserine combinations
|
|
HRP20140174T1
(hr)
*
|
2009-02-27 |
2014-04-25 |
Ambit Biosciences Corporation |
Derivati kinazolina kao modulatori jak-kinaze i postupci njihove upotrebe
|
|
CA2755095A1
(en)
*
|
2009-03-09 |
2010-09-16 |
Surface Logix, Inc. |
Rho kinase inhibitors
|
|
KR20110131302A
(ko)
*
|
2009-03-23 |
2011-12-06 |
엠에스디 가부시키가이샤 |
오로라 ａ 선택적 억제 작용을 갖는 신규한 아미노피리딘 유도체
|
|
US8367690B2
(en)
*
|
2009-03-24 |
2013-02-05 |
Vertex Pharmaceuticals Inc. |
Aminopyridine derivatives having aurora a selective inhibitory action
|
|
CN102438626B
(zh)
*
|
2009-03-24 |
2014-01-15 |
Msdk.K.公司 |
具有Aurora A选择性抑制作用的新型氨基吡啶衍生物
|
|
US8211901B2
(en)
|
2009-05-22 |
2012-07-03 |
Shenzhen Chipscreen Biosciences Ltd. |
Naphthamide derivatives as multi-target protein kinase inhibitors and histone deacetylase inhibitors
|
|
CN101906076B
(zh)
|
2009-06-04 |
2013-03-13 |
深圳微芯生物科技有限责任公司 |
作为蛋白激酶抑制剂和组蛋白去乙酰化酶抑制剂的萘酰胺衍生物、其制备方法及应用
|
|
CN105175409A
(zh)
*
|
2009-06-08 |
2015-12-23 |
南特生物科学公司 |
三嗪衍生物及其治疗应用
|
|
KR20120016676A
(ko)
*
|
2009-06-09 |
2012-02-24 |
아브락시스 바이오사이언스, 엘엘씨 |
우레이도페닐치환 트리아진 유도체와 이들의 치료적 용도
|
|
JP5785940B2
(ja)
*
|
2009-06-09 |
2015-09-30 |
アブラクシス バイオサイエンス， エルエルシー |
トリアジン誘導体類及びそれらの治療応用
|
|
CA2766151A1
(en)
*
|
2009-06-24 |
2010-12-29 |
Genentech, Inc. |
Oxo-heterocycle fused pyrimidine compounds, compositions and methods of use
|
|
US8637525B2
(en)
|
2009-07-31 |
2014-01-28 |
Bristol-Myers Squibb Company |
Compounds for the reduction of beta-amyloid production
|
|
TWI468402B
(zh)
*
|
2009-07-31 |
2015-01-11 |
必治妥美雅史谷比公司 |
降低β－類澱粉生成之化合物
|
|
US20110053916A1
(en)
|
2009-08-14 |
2011-03-03 |
Vertex Pharmaceuticals Incorporated |
Pyrimidine compounds as tuberculosis inhibitors
|
|
CN102020657A
(zh)
*
|
2009-09-11 |
2011-04-20 |
上海艾力斯医药科技有限公司 |
稠合杂芳基衍生物、制备方法及其应用
|
|
CA2780018C
(en)
|
2009-11-12 |
2015-10-20 |
F. Hoffmann-La Roche Ag |
N-7 substituted purine and pyrazolopyrimidine compounds, compositions and methods of use
|
|
KR101469334B1
(ko)
|
2009-11-12 |
2014-12-04 |
에프. 호프만-라 로슈 아게 |
Ｎ-9-치환된 퓨린 화합물, 조성물 및 사용 방법
|
|
AU2011215638B2
(en)
*
|
2010-02-11 |
2016-04-28 |
Vanderbilt University |
Pyrazolopyridine, pyrazolopyrazine, pyrazolopyrimidine, pyrazolothiophene and pyrazolothiazole compounds as mGluR4 allosteric potentiators, compounds, and methods of treating neurological dysfunction
|
|
NZ602838A
(en)
|
2010-04-07 |
2015-06-26 |
Vertex Pharma |
Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid and administration thereof
|
|
MX2012013274A
(es)
|
2010-05-21 |
2013-05-28 |
Chemilia Ab |
Novedosos derivados de la pirimidina.
|
|
PT2576541T
(pt)
|
2010-06-04 |
2016-07-08 |
Hoffmann La Roche |
Derivados de aminopirimidina como moduladores de lrrk2
|
|
US20110319409A1
(en)
*
|
2010-06-23 |
2011-12-29 |
Cox Christopher D |
7-aza-quinazoline pde10 inhibitors
|
|
JP5901634B2
(ja)
|
2010-09-01 |
2016-04-13 |
アムビト ビオスシエンセス コルポラチオン |
キナゾリン化合物及びその使用方法
|
|
EP2621914B1
(en)
|
2010-09-27 |
2016-12-28 |
Abbott GmbH & Co. KG |
Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
|
|
WO2012059932A1
(en)
|
2010-11-01 |
2012-05-10 |
Aurigene Discovery Technologies Limited |
2, 4 -diaminopyrimidine derivatives as protein kinase inhibitors
|
|
CA2816957A1
(en)
|
2010-11-07 |
2012-05-10 |
Targegen, Inc. |
Compositions and methods for treating myelofibrosis
|
|
CA2812669C
(en)
|
2010-11-10 |
2018-11-06 |
F. Hoffmann-La Roche Ag |
Pyrazole aminopyrimidine derivatives as lrrk2 modulators
|
|
EP2651404B1
(en)
|
2010-12-14 |
2015-10-14 |
Electrophoretics Limited |
Casein kinase 1delta (ck1delta) inhibitors
|
|
BR112013015449A2
(pt)
|
2010-12-21 |
2016-09-20 |
Novartis Ag |
compostos de bi-heteroarila como inibidores de vps23
|
|
US9090592B2
(en)
|
2010-12-30 |
2015-07-28 |
AbbVie Deutschland GmbH & Co. KG |
Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
|
|
WO2012101654A2
(en)
*
|
2011-01-25 |
2012-08-02 |
Sphaera Pharma Pvt. Ltd |
Novel triazine compounds
|
|
RU2013147417A
(ru)
|
2011-03-24 |
2015-04-27 |
Кемилиа Аб |
Новые производные пиримидина
|
|
SG194045A1
(en)
|
2011-04-01 |
2013-11-29 |
Genentech Inc |
Combinations of akt inhibitor compounds and abiraterone, and methods of use
|
|
US9682082B2
(en)
|
2011-04-01 |
2017-06-20 |
Genentech, Inc. |
Combinations of AKT and MEK inhibitor compounds, and methods of use
|
|
RU2477723C2
(ru)
|
2011-06-16 |
2013-03-20 |
Общество С Ограниченной Ответственностью "Фьюжн Фарма" |
Ингибиторы протеинкиназ (варианты), их применение для лечения онкологических заболеваний и фармацевтическая композиция на их основе
|
|
JP6027610B2
(ja)
|
2011-07-19 |
2016-11-16 |
インフィニティー ファーマシューティカルズ， インコーポレイテッド |
複素環式化合物及びその使用
|
|
US8846656B2
(en)
|
2011-07-22 |
2014-09-30 |
Novartis Ag |
Tetrahydropyrido-pyridine and tetrahydropyrido-pyrimidine compounds and use thereof as C5a receptor modulators
|
|
MX2014002208A
(es)
|
2011-08-25 |
2014-05-28 |
Hoffmann La Roche |
Inhibidores de serina/treonina quinasa.
|
|
PL2755483T3
(pl)
|
2011-09-14 |
2019-06-28 |
Samumed, Llc |
Indazolo-3-karboksyamidy i ich zastosowanie jako inhibitorów szlaków sygnalizacji WNT/B-kateniny
|
|
WO2013042006A1
(en)
|
2011-09-22 |
2013-03-28 |
Pfizer Inc. |
Pyrrolopyrimidine and purine derivatives
|
|
ES2645968T3
(es)
|
2011-09-27 |
2017-12-11 |
Novartis Ag |
3-(pirimidin-4-il)-oxazolidin-2-onas como inhibidores de IDH mutante
|
|
EP2794605A1
(en)
|
2011-12-22 |
2014-10-29 |
F.Hoffmann-La Roche Ag |
2, 4-diamine-pyrimidine derivative as serine/threonine kinase inhibitors
|
|
PT2806859T
(pt)
|
2012-01-25 |
2019-09-04 |
Vertex Pharma |
Formulações de ácido 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-il)ciclopropanocarboxamido)-3-metilpiridin-2-il)benzoico
|
|
UY34632A
(es)
|
2012-02-24 |
2013-05-31 |
Novartis Ag |
Compuestos de oxazolidin- 2- ona y usos de los mismos
|
|
WO2013138617A1
(en)
*
|
2012-03-16 |
2013-09-19 |
Axikin Pharmaceuticals, Inc. |
3,5-diaminopyrazole kinase inhibitors
|
|
EP2828250B1
(en)
*
|
2012-03-19 |
2021-03-10 |
Imperial College Innovations Limited |
Quinazoline compounds and their use in therapy
|
|
US20130303519A1
(en)
|
2012-03-20 |
2013-11-14 |
Millennium Pharmaceuticals, Inc. |
Methods of treating cancer using aurora kinase inhibitors
|
|
PH12017500997A1
(en)
|
2012-04-04 |
2018-02-19 |
Samumed Llc |
Indazole inhibitors of the wnt signal pathway and therapeutic uses thereof
|
|
SG10201704095UA
(en)
|
2012-04-24 |
2017-06-29 |
Vertex Pharma |
Dna-pk inhibitors
|
|
WO2013164323A1
(en)
*
|
2012-05-03 |
2013-11-07 |
F. Hoffmann-La Roche Ag |
Pyrazole aminopyrimidine derivatives as lrrk2 modulators for use in the treatment of parkinson's disease
|
|
MX363118B
(es)
*
|
2012-05-03 |
2019-03-11 |
Genentech Inc |
Derivados de pirazol aminopirimidina como moduladores de cinasa 2 de repeticion rica en leucina (lrrk2).
|
|
KR20150034209A
(ko)
|
2012-06-26 |
2015-04-02 |
델 마 파마슈티컬스 인코포레이티드 |
디안하이드로갈락티톨, 디아세틸디안하이드로갈락티톨, 디브로모둘시톨, 또는 그의 유사체 또는 유도체를 이용하여 유전학적 다형성이 있는 환자에 있어서 티로신-키나아제-억제제 내성 악성종양, ahi1 조절곤란 또는 돌연변이를 치료하는 방법
|
|
WO2014052699A1
(en)
|
2012-09-28 |
2014-04-03 |
Cephalon, Inc. |
Azaquinazoline inhibitors of atypical protein kinase c
|
|
JO3470B1
(ar)
|
2012-10-08 |
2020-07-05 |
Merck Sharp & Dohme |
مشتقات 5- فينوكسي-3h-بيريميدين-4-أون واستخدامها كمثبطات ناسخ عكسي ل hiv
|
|
DK2909181T3
(da)
*
|
2012-10-16 |
2017-11-20 |
Tolero Pharmaceuticals Inc |
PKM2-modulatorer og fremgangsmåder til anvendelse deraf
|
|
US9296733B2
(en)
|
2012-11-12 |
2016-03-29 |
Novartis Ag |
Oxazolidin-2-one-pyrimidine derivative and use thereof for the treatment of conditions, diseases and disorders dependent upon PI3 kinases
|
|
EP3181564B1
(en)
*
|
2012-11-20 |
2019-09-18 |
H. Hoffnabb-La Roche Ag |
Aminopyrimidine compounds as inhibitors of t790m containing egfr mutants
|
|
JP6412503B2
(ja)
|
2012-11-21 |
2018-10-24 |
ピーティーシー セラピューティクス， インコーポレイテッド |
置換逆ピリミジンＢｍｉ−１阻害剤
|
|
CN103012428A
(zh)
|
2013-01-08 |
2013-04-03 |
中国药科大学 |
4-(五元杂环并嘧啶/吡啶取代)氨基-1H-3-吡唑甲酰胺类CDK/Aurora双重抑制剂及其用途
|
|
US9908867B2
(en)
|
2013-01-08 |
2018-03-06 |
Samumed, Llc |
3-(benzoimidazol-2-yl)-indazole inhibitors of the Wnt signaling pathway and therapeutic uses thereof
|
|
JP6424173B2
(ja)
|
2013-02-04 |
2018-11-14 |
ヤンセン ファーマシューティカ エヌ．ベー． |
Ｆｌａｐ調節因子
|
|
TWI644899B
(zh)
|
2013-02-04 |
2018-12-21 |
健生藥品公司 |
Ｆｌａｐ調節劑
|
|
EP2769722A1
(en)
*
|
2013-02-22 |
2014-08-27 |
Ruprecht-Karls-Universität Heidelberg |
Compounds for use in inhibiting HIV capsid assembly
|
|
JO3377B1
(ar)
*
|
2013-03-11 |
2019-03-13 |
Takeda Pharmaceuticals Co |
مشتقات بيريدينيل وبيريدينيل مندمج
|
|
PT2970218T
(pt)
|
2013-03-12 |
2019-03-01 |
Vertex Pharma |
Inibidores de adn-pk
|
|
AU2014229313B2
(en)
|
2013-03-14 |
2016-07-28 |
Novartis Ag |
3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH
|
|
CA2907726A1
(en)
|
2013-03-22 |
2014-09-25 |
Millennium Pharmaceuticals, Inc. |
Combination of catalytic mtorc1/2 inhibitors and selective inhibitors of aurora a kinase
|
|
EP3024456A4
(en)
|
2013-07-26 |
2017-04-12 |
Update Pharma Inc. |
Combinatorial methods to improve the therapeutic benefit of bisantrene
|
|
CA2922657C
(en)
|
2013-08-30 |
2022-04-12 |
Ptc Therapeutics, Inc. |
Substituted pyrimidine bmi-1 inhibitors
|
|
WO2015028848A1
(en)
*
|
2013-09-02 |
2015-03-05 |
Piramal Enterprises Limited |
Bicyclic heterocyclic compounds as multi-kinase inhibitors
|
|
US9624228B2
(en)
|
2013-10-03 |
2017-04-18 |
Kura Oncology, Inc. |
Inhibitors of ERK and methods of use
|
|
US10125144B2
(en)
|
2013-10-07 |
2018-11-13 |
Kadmon Corporation, Llc |
Rho kinase inhibitors
|
|
SG11201602962PA
(en)
|
2013-10-17 |
2016-05-30 |
Vertex Pharma |
Co-crystals of (s)-n-methyl-8-(1-((2'-methyl-[4,5'-bipyrimidin]-6-yl)amino)propan-2-yl)quinoline-4-carboxamide and deuterated derivatives thereof as dna-pk inhibitors
|
|
WO2015073231A1
(en)
|
2013-11-12 |
2015-05-21 |
Vertex Pharmaceuticals Incorporated |
Process of preparing pharmaceutical compositions for the treatment of cftr mediated diseases
|
|
US9975878B2
(en)
|
2013-11-21 |
2018-05-22 |
Ptc Therapeutics, Inc. |
Substituted triazine BMI-1 inhibitors
|
|
UA115388C2
(uk)
|
2013-11-21 |
2017-10-25 |
Пфайзер Інк. |
2,6-заміщені пуринові похідні та їх застосування в лікуванні проліферативних захворювань
|
|
EP3071553A4
(en)
*
|
2013-11-21 |
2017-08-02 |
PTC Therapeutics, Inc. |
Substituted pyridine and pyrazine bmi-1 inhibitors
|
|
CN104672250B
(zh)
*
|
2013-11-29 |
2017-11-07 |
广东东阳光药业有限公司 |
取代的杂芳基化合物及其组合物和用途
|
|
CN109045032A
(zh)
*
|
2014-01-01 |
2018-12-21 |
麦迪威森技术有限责任公司 |
氨基吡啶类化合物和使用方法
|
|
WO2015112739A1
(en)
*
|
2014-01-22 |
2015-07-30 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Compounds and method for treating parp1-deficient cancers
|
|
CN104926795B
(zh)
*
|
2014-03-17 |
2017-11-10 |
广东东阳光药业有限公司 |
取代的杂芳基化合物及其组合物和用途
|
|
TWI675836B
(zh)
*
|
2014-03-25 |
2019-11-01 |
美商伊格尼塔公司 |
非典型蛋白質激酶ｃ之氮雜喹唑啉抑制劑
|
|
US20170165230A1
(en)
|
2014-04-09 |
2017-06-15 |
Christopher Rudd |
Use of gsk-3 inhibitors or activators which modulate pd-1 or t-bet expression to modulate t cell immunity
|
|
CN105367555B
(zh)
*
|
2014-08-07 |
2019-06-25 |
广东东阳光药业有限公司 |
取代的杂芳基化合物及其组合物和用途
|
|
WO2016040180A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(1h-benzo[d]imidazol-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
|
|
WO2016040190A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridine and therapeutic uses thereof
|
|
WO2016040193A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridine and therapeutic uses thereof
|
|
WO2016040184A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
|
|
WO2016040181A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
|
|
WO2016040185A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
2-(1h-indazol-3-yl)-3h-imidazo[4,5-b]pyridine and therapeutic uses thereof
|
|
SG11201703963QA
(en)
|
2014-11-18 |
2017-06-29 |
Vertex Pharma |
Process of conducting high throughput testing high performance liquid chromatography
|
|
WO2016106009A1
(en)
*
|
2014-12-22 |
2016-06-30 |
Eli Lilly And Company |
Erk inhibitors
|
|
TWI704151B
(zh)
*
|
2014-12-22 |
2020-09-11 |
美商美國禮來大藥廠 |
Ｅｒｋ抑制劑
|
|
WO2016123627A1
(en)
|
2015-01-30 |
2016-08-04 |
Vanderbilt University |
Isoquiniline and napthalene-substituted compounds as mglur4 allosteric potentiators, compounds, and methods of treating neurological dysfunction
|
|
EP3070084A1
(en)
*
|
2015-03-18 |
2016-09-21 |
Rottapharm Biotech S.r.l. |
New fyn kinase inhibitors
|
|
CA2982890C
(en)
|
2015-04-17 |
2023-08-22 |
Ludwig Institute For Cancer Research Ltd |
Plk4 inhibitors
|
|
US10118904B2
(en)
|
2015-06-05 |
2018-11-06 |
Vertex Pharmaceuticals Incorporated |
Triazoles for the treatment of Demyelinating Diseases
|
|
WO2017024004A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[2,3-b]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
|
WO2017023988A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(3h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
|
US10166218B2
(en)
|
2015-08-03 |
2019-01-01 |
Samumed, Llc |
3-(1H-indol-2-yl)-1H-pyrazolo[3,4-C]pyridines and therapeutic uses thereof
|
|
WO2017023993A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-indol-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
|
US10285982B2
(en)
|
2015-08-03 |
2019-05-14 |
Samumed, Llc |
3-(1H-pyrrolo[2,3-B]pyridin-2-yl)-1H-pyrazolo[3,4-C]pyridines and therapeutic uses thereof
|
|
WO2017024015A1
(en)
*
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
|
US10383861B2
(en)
|
2015-08-03 |
2019-08-20 |
Sammumed, LLC |
3-(1H-pyrrolo[2,3-C]pyridin-2-yl)-1H-pyrazolo[3,4-C]pyridines and therapeutic uses thereof
|
|
WO2017024021A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc |
3-(1h-pyrrolo[2,3-b]pyridin-2-yl)-1h-indazoles and therapeutic uses thereof
|
|
WO2017023986A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc |
3-(1h-indol-2-yl)-1h-indazoles and therapeutic uses thereof
|
|
US10195185B2
(en)
|
2015-08-03 |
2019-02-05 |
Samumed, Llc |
3-(1H-imidazo[4,5-C]pyridin-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
|
US10392383B2
(en)
|
2015-08-03 |
2019-08-27 |
Samumed, Llc |
3-(1H-benzo[d]imidazol-2-yl)-1H-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
|
US10231956B2
(en)
|
2015-08-03 |
2019-03-19 |
Samumed, Llc |
3-(1H-pyrrolo[3,2-C]pyridin-2-YL)-1 H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
|
US10463651B2
(en)
|
2015-08-03 |
2019-11-05 |
Samumed, Llc |
3-(1H-pyrrolo[3,2-C]pyridin-2-YL)-1H-indazoles and therapeutic uses thereof
|
|
WO2017024025A1
(en)
|
2015-08-03 |
2017-02-09 |
Sunil Kumar Kc |
3-(1h-pyrrolo[2,3-c]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
|
US10226448B2
(en)
|
2015-08-03 |
2019-03-12 |
Samumed, Llc |
3-(1H-pyrrolo[3,2-C]pyridin-2-yl)-1H-pyrazolo[3,4-B]pyridines and therapeutic uses thereof
|
|
WO2017023984A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[3,2-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridines and therapeutic uses thereof
|
|
WO2017023996A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[2,3-b]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridines and therapeutic uses thereof
|
|
MX389958B
(es)
|
2015-11-06 |
2025-03-20 |
Samumed Llc |
2- (1h-indazol-3-il) -3h-imidazo[4,5-c] piridinas y usos antiinflamatorios de las mismas.
|
|
GB201604647D0
(en)
*
|
2016-03-18 |
2016-05-04 |
Mission Therapeutics Ltd |
Novel compounds
|
|
MY199242A
(en)
|
2016-06-01 |
2023-10-22 |
Samumed Llc |
Process for preparing n-(5-(3-(7-(3-fluorophenyl)-3h-imidazo[4,5-c]pyridin-2-yl)-1h-indazol-5-yl)pyridin-3-yl)-3-methylbutanamide
|
|
RU2758669C2
(ru)
|
2016-09-27 |
2021-11-01 |
Вертекс Фармасьютикалз Инкорпорейтед |
Способ лечения рака с применением сочетания днк-поражающих агентов и ингибиторов днк-пк
|
|
WO2018075858A1
(en)
|
2016-10-21 |
2018-04-26 |
Samumed, Llc |
Methods of using indazole-3-carboxamides and their use as wnt/b-catenin signaling pathway inhibitors
|
|
US10870630B2
(en)
|
2016-11-01 |
2020-12-22 |
Merck Sharp & Dohme Corp. |
Substituted bicyclic heteroaryl allosteric modulators of nicotinic acetylcholine receptors
|
|
MA46696A
(fr)
|
2016-11-07 |
2019-09-11 |
Samumed Llc |
Formulations injectables à dose unique prêtes à l'emploi
|
|
IT201700047189A1
(it)
*
|
2017-05-02 |
2018-11-02 |
Fondazione St Italiano Tecnologia |
Composti e composizioni per il trattamento di cancro, disordini della retina e cardiomiopatie
|
|
AR112027A1
(es)
*
|
2017-06-15 |
2019-09-11 |
Biocryst Pharm Inc |
Inhibidores de alk 2 quinasa que contienen imidazol
|
|
ES2969536T3
(es)
|
2017-06-30 |
2024-05-21 |
Beijing Tide Pharmaceutical Co Ltd |
Inhibidor de la proteína cinasa asociada a rho, composición farmacéutica que lo comprende, y su método de preparación y uso
|
|
CN110582491B
(zh)
|
2017-06-30 |
2023-09-29 |
北京泰德制药股份有限公司 |
Rho相关蛋白激酶抑制剂、包含其的药物组合物及其制备方法和用途
|
|
ES2930804T3
(es)
*
|
2017-06-30 |
2022-12-22 |
Beijing Tide Pharmaceutical Co Ltd |
Inhibidor de proteína cinasa asociada a RHO, composición farmacéutica que lo comprende, así como método de preparación y uso del mismo
|
|
CN109384774B
(zh)
*
|
2017-08-11 |
2023-02-17 |
中国科学院上海药物研究所 |
一类多取代的吡嗪/三嗪酰胺类化合物及其制备方法和应用
|
|
HRP20221221T1
(hr)
|
2017-10-27 |
2022-12-09 |
Theravance Biopharma R&D Ip, Llc |
Pirimidinski spoj kao inhibitor jak kinaze
|
|
GB201801226D0
(en)
*
|
2018-01-25 |
2018-03-14 |
Redx Pharma Plc |
Modulators of Rho-associated protein kinase
|
|
US12030857B2
(en)
*
|
2018-06-25 |
2024-07-09 |
Kadmon Corporation, Llc |
Glucose uptake inhibitors
|
|
BR112021002630A2
(pt)
|
2018-08-17 |
2021-05-11 |
Ptc Therapeutics, Inc. |
método para tratar câncer pancreático
|
|
CN112739698A
(zh)
|
2018-08-24 |
2021-04-30 |
捷豹治疗有限公司 |
作为ahr调节剂的四氢嘧啶衍生物
|
|
KR102328682B1
(ko)
*
|
2018-08-27 |
2021-11-18 |
주식회사 대웅제약 |
신규한 헤테로사이클릭아민 유도체 및 이를 포함하는 약학 조성물
|
|
WO2020045941A1
(ko)
*
|
2018-08-27 |
2020-03-05 |
주식회사 대웅제약 |
신규한 헤테로사이클릭아민 유도체 및 이를 포함하는 약학 조성물
|
|
US11066404B2
(en)
|
2018-10-11 |
2021-07-20 |
Incyte Corporation |
Dihydropyrido[2,3-d]pyrimidinone compounds as CDK2 inhibitors
|
|
GEAP202315703A
(en)
|
2018-12-27 |
2023-02-27 |
Les Laboratoires Servier |
Aza-heterobicyclic inhibitors of mat2a and methods of use for treating cancer
|
|
MX2021008152A
(es)
*
|
2019-01-03 |
2021-10-13 |
Univ Pittsburgh Commonwealth Sys Higher Education |
Metodos y materiales para aumentar los niveles del polipeptido del factor de transcripcion eb.
|
|
EP3920885A1
(en)
|
2019-02-08 |
2021-12-15 |
Frequency Therapeutics, Inc. |
Valproic acid compounds and wnt agonists for treating ear disorders
|
|
WO2020168197A1
(en)
|
2019-02-15 |
2020-08-20 |
Incyte Corporation |
Pyrrolo[2,3-d]pyrimidinone compounds as cdk2 inhibitors
|
|
WO2020180959A1
(en)
|
2019-03-05 |
2020-09-10 |
Incyte Corporation |
Pyrazolyl pyrimidinylamine compounds as cdk2 inhibitors
|
|
KR20210141621A
(ko)
|
2019-03-22 |
2021-11-23 |
스미토모 다이니폰 파마 온콜로지, 인크. |
Pkm2 조정제를 포함하는 조성물 및 그를 사용한 치료 방법
|
|
WO2020192750A1
(zh)
|
2019-03-28 |
2020-10-01 |
江苏恒瑞医药股份有限公司 |
噻吩并杂环类衍生物、其制备方法及其在医药上的应用
|
|
BR112021018924A2
(pt)
|
2019-03-29 |
2022-02-01 |
Jiangsu Hengrui Medicine Co |
Derivado de heterocíclico pirrol, método de preparação do mesmo e aplicação do mesmo em medicamento
|
|
WO2020205560A1
(en)
|
2019-03-29 |
2020-10-08 |
Incyte Corporation |
Sulfonylamide compounds as cdk2 inhibitors
|
|
CN109826608A
(zh)
*
|
2019-04-08 |
2019-05-31 |
中国科学院地质与地球物理研究所 |
一种分段压裂装置
|
|
AU2020260629A1
(en)
*
|
2019-04-22 |
2021-12-09 |
Betta Pharmaceuticals Co., Ltd |
Quinazoline compound and pharmaceutical application thereof
|
|
ES2974577T3
(es)
|
2019-04-24 |
2024-06-27 |
Theravance Biopharma R&D Ip Llc |
Compuestos éster y carbonato de pirimidina como inhibidores de JAK quinasa
|
|
ES2994097T3
(en)
|
2019-04-24 |
2025-01-17 |
Theravance Biopharma R&D Ip Llc |
Pyrimidine jak inhibitors for the treatment of skin diseases
|
|
WO2020223558A1
(en)
|
2019-05-01 |
2020-11-05 |
Incyte Corporation |
Tricyclic amine compounds as cdk2 inhibitors
|
|
WO2020223469A1
(en)
|
2019-05-01 |
2020-11-05 |
Incyte Corporation |
N-(1-(methylsulfonyl)piperidin-4-yl)-4,5-di hydro-1h-imidazo[4,5-h]quinazolin-8-amine derivatives and related compounds as cyclin-dependent kinase 2 (cdk2) inhibitors for treating cancer
|
|
CN113825757B
(zh)
|
2019-05-24 |
2023-10-20 |
江苏恒瑞医药股份有限公司 |
取代的稠合双环类衍生物、其制备方法及其在医药上的应用
|
|
WO2020243519A1
(en)
*
|
2019-05-29 |
2020-12-03 |
Ifm Due, Inc. |
Compounds and compositions for treating conditions associated with sting activity
|
|
TW202115024A
(zh)
|
2019-08-14 |
2021-04-16 |
美商英塞特公司 |
作為cdk2 抑制劑之咪唑基嘧啶基胺化合物
|
|
JP2022547882A
(ja)
*
|
2019-09-06 |
2022-11-16 |
インフレイゾーム リミテッド |
Ｎｌｒｐ３阻害剤
|
|
EP4041399A1
(en)
*
|
2019-10-02 |
2022-08-17 |
Tolremo Therapeutics AG |
Heterocyclic derivatives, pharmaceutical compositions and their use in the treatment or amelioration of cancer
|
|
PE20221905A1
(es)
|
2019-10-11 |
2022-12-23 |
Incyte Corp |
Aminas biciclicas como inhibidoras de la cdk2
|
|
MX2022008627A
(es)
|
2020-01-13 |
2022-11-08 |
Verge Analytics Inc |
Pirazolo-pirimidinas sustituidas y usos de las mismas.
|
|
US20230279000A1
(en)
*
|
2020-02-26 |
2023-09-07 |
Jaguahr Therapeutics Pte Ltd |
Pyridopyrimidine derivatives useful in modulation of ahr signalling
|
|
KR20250151616A
(ko)
*
|
2020-03-27 |
2025-10-21 |
동아에스티 주식회사 |
아미노피리미딘 유도체 및 이의 아릴 탄화수소 수용체 조절제로서의 용도
|
|
JP2023533464A
(ja)
|
2020-06-25 |
2023-08-03 |
トルレモ・セラピューティクス・アクチェンゲゼルシャフト |
がんを治療するための、ＣＢＰ／ｐ３００ブロモドメイン阻害剤およびＫＲＡＳ阻害剤の組合せ
|
|
FI4182308T3
(fi)
|
2020-07-15 |
2024-12-07 |
Chiesi Farm Spa |
Pyridatsinyyliaminojohdannaisia alk5-estäjinä
|
|
WO2022032484A1
(zh)
*
|
2020-08-11 |
2022-02-17 |
北京诺诚健华医药科技有限公司 |
哒嗪-3-甲酰胺类化合物、其制备方法及其在医药学上的应用
|
|
CN114149410B
(zh)
*
|
2020-09-07 |
2025-02-25 |
四川科伦博泰生物医药股份有限公司 |
吡啶并环类化合物及其制备方法和用途
|
|
CN116437915B
(zh)
|
2020-09-29 |
2025-03-18 |
江苏恒瑞医药股份有限公司 |
一种吡咯并杂环类衍生物的晶型及其制备方法
|
|
WO2022107919A1
(ko)
*
|
2020-11-19 |
2022-05-27 |
주식회사 보로노이 |
N을 포함하는 헤테로아릴 유도체 및 이를 유효성분으로 포함하는 단백질 키나아제 관련 질환의 예방 또는 치료용 약학적 조성물
|
|
CA3211872A1
(en)
*
|
2021-03-24 |
2022-09-29 |
Athos Therapeutics, Inc. |
Small molecules for the treatment of kinase-related diseases
|
|
US11981671B2
(en)
|
2021-06-21 |
2024-05-14 |
Incyte Corporation |
Bicyclic pyrazolyl amines as CDK2 inhibitors
|
|
JP2024524373A
(ja)
|
2021-06-28 |
2024-07-05 |
ブループリント メディシンズ コーポレイション |
Ｃｄｋ２阻害剤
|
|
TW202328102A
(zh)
|
2021-09-21 |
2023-07-16 |
義大利商吉斯藥品公司 |
作為ａｌｋ５抑制劑之嗒𠯤基胺基衍生物
|
|
CN116023380B
(zh)
*
|
2021-10-26 |
2024-01-23 |
沈阳药科大学 |
一类吡唑并嘧啶衍生物及制备方法和应用
|
|
US11976073B2
(en)
|
2021-12-10 |
2024-05-07 |
Incyte Corporation |
Bicyclic amines as CDK2 inhibitors
|
|
CA3242851A1
(en)
|
2022-01-11 |
2025-02-27 |
Chiesi Farmaceutici S.P.A. |
PYRIDAZINYL AMINO DERIVATIVES USED AS ALK5 INHIBITORS
|
|
WO2024206628A1
(en)
*
|
2023-03-30 |
2024-10-03 |
Nalo Therapeutics |
Modulators of myc family proto-oncogene protein
|